CASEY TRIBBLE: Open Payments
NPI 1649639253 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 53 payments from 17 companies in 2025. Trend: 2023 $1,641 · 2024 $1,253 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 4 | $190 |
| Merck Sharp & Dohme LLC | 8 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $140 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $140 |
| Boston Scientific Corporation | 4 | $119 |
| Kestra Medical Technology Services, Inc. | 2 | $62 |
| PFIZER INC. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Amgen Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: AMVUTTRA, VERQUVO, JARDIANCE, LifeVest, WATCHMAN FLX, Assure WCD, ELIQUIS, LEQVIO.
Industry payments across MO — which companies pay providers there.
